glp 1 for cardiovascular disease Cardiometabolic effects of GLP-1 analogs in obese and overweight patients with preexisting disease: A systematic review and meta analysis of randomized controlled trials Patients with diabetes who remained

Semaglutide's seven-day half-life means drug levels drop significantly after one week, reducing appetite suppression and potentially causing side effects when you resume dosing

You can get there by trimming calories, moving more, or both

Ideal for days when solid food is difficult

Nature 546 , 248253 (2017)

The glucagon receptor component adds metabolic effects beyond appetite suppression, including enhanced fat oxidation and energy expenditure

Disclosures: David Garcia: Nothing to Disclose, Edgar Villavicencio: Nothing to Disclose, Caitlin Baird: Nothing to Disclose, Xiaoxiao Sun: Nothing to Disclose, Timian Godfrey: Nothing to Disclose, Kimberly Shea: Nothing to Disclose, Adriana Maldonado: Nothing to Disclose, Denver Seaton: Nothing to Disclose, Priscilla Sanderson: Nothing to Disclose 1125 IMPACT OF SURVEILLANCE ON OVERALL SURVIVAL IN PATIENTS WITH MASLD-ASSOCIATED HEPATOCELLULAR CARCINOMA: